RespireRx Pharmaceuticals Inc (RSPI)

[haysaw]

That's something that you have been citing Neuro

Exactly. The detrimental issue has nothing to do with raising capital, per se. It has to do with a mgmt team not realizing their own incompetence, and therefore, not getting out of their own way for the sake of the company and shareholders. That takes me back to the Catch 22 dilemma I introduced recently: A good mgmt team would have figured that out.